A method for determining related substances in trexagliptin succinate raw material
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 中山万远新药研发有限公司
- Publication Date
- 2017-03-29
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of analytical chemistry, in particular to a method for determining related substances in trexagliptin raw materials. Background technique
[0002] Among the antidiabetic drugs, the research of orally administered small molecule DPP-IV inhibitors is the most active. DPP-IV is an enzyme in the body that triggers the inactivation of incretins, glucone-like peptide-1 and glucose-dependent insulinotropic polypeptide, two incretins that play an important role in blood glucose regulation . Inhibition of DPP-IV can increase blood glucose level-dependent insulin secretion, thereby controlling blood glucose levels.
[0003] DPP-IV inhibitor drugs are named "gliptins". There are 17 such drugs. Among them, trexagliptin was developed by Takeda Pharmaceutical and was first approved for marketing in Japan in 2014. It is an ultra-long-acting The DPP-IV inhibitor only needs to be taken orally once a week, which can produce continuo...